|Last Price$85.56||Day Change (%)-2.36%|
|Open Price$87.31||Day Change ($)-2.07|
|Day Range85.25–88.82||52-Week Range70.67–94.87|
As of Fri 2/5/2016 5:43:00 PM | USD
Exelixis Announces Positive Overall Survival Results from METEOR, the Phase 3 Pivotal Trial of Cabozantinib in Advanced Renal Cell Carcinoma
Exelixis Submits Marketing Authorization Application in the European Union for Cabozantinib as a Treatment for Advanced Renal Cell Carcinoma
The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...